Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial
Obstetrics & Gynecology
•
February 01, 2026
Cabergoline reduces post-loss lactation symptoms
A single 1 mg dose of cabergoline reduced breast symptoms after abortion or pregnancy loss at 16–20 weeks. *Double-blind randomized controlled trial; Oxford evidence Level 1b.
- Level of evidence
- Level 1b
- DocG quality score
- 6.4 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
